Akero Therapeutics, Inc. Operating Cash Flow
Akero Therapeutics, Inc. reported Operating Cash Flow of -$183.08 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-07
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$67.17M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$48.25M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$67.66M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$67.09M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$230.11M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$145.37M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$92.52M.
- Akero Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$79.68M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$67.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$115.42M derived: sum of 2 quarters · filed 2025-11-07 | -$183.08M 10-Q · filed 2025-11-07 | -$250.17M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | -$48.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$115.91M 10-Q · filed 2025-08-08 | -$183.00M derived: sum of 3 quarters · filed 2025-08-08 | -$253.42M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-03-31 | -$67.66M 10-Q · filed 2025-05-12 | -$134.75M derived: sum of 2 quarters · filed 2025-05-12 | -$205.18M derived: sum of 3 quarters · filed 2025-11-07 | -$262.63M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-12-31 | -$67.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$137.51M derived: sum of 2 quarters · filed 2025-11-07 | -$194.97M derived: sum of 3 quarters · filed 2025-11-07 | -$230.11M 10-K · filed 2025-02-28 |
| 2024-09-30 | -$70.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$127.88M derived: sum of 2 quarters · filed 2025-11-07 | -$163.02M 10-Q · filed 2025-11-07 | -$211.64M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$57.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$92.59M 10-Q · filed 2025-08-08 | -$141.22M derived: sum of 3 quarters · filed 2025-08-08 | -$190.94M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$35.14M 10-Q · filed 2025-05-12 | -$83.77M derived: sum of 2 quarters · filed 2025-05-12 | -$133.49M derived: sum of 3 quarters · filed 2025-05-12 | -$155.88M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$48.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$98.35M derived: sum of 2 quarters · filed 2025-02-28 | -$120.73M derived: sum of 3 quarters · filed 2025-02-28 | -$145.37M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$49.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$72.11M derived: sum of 2 quarters · filed 2024-11-08 | -$96.74M 10-Q · filed 2024-11-08 | -$122.25M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$22.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$47.02M 10-Q · filed 2024-08-09 | -$72.53M derived: sum of 3 quarters · filed 2025-02-28 | -$97.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$24.63M 10-Q · filed 2024-05-10 | -$50.14M derived: sum of 2 quarters · filed 2025-02-28 | -$74.76M derived: sum of 3 quarters · filed 2025-02-28 | -$94.27M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$25.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$50.13M derived: sum of 2 quarters · filed 2025-02-28 | -$69.64M derived: sum of 3 quarters · filed 2025-02-28 | -$92.52M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$24.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$44.13M derived: sum of 2 quarters · filed 2023-11-13 | -$67.01M 10-Q · filed 2023-11-13 | -$93.70M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$19.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$42.38M 10-Q · filed 2023-08-11 | -$69.08M derived: sum of 3 quarters · filed 2024-02-29 | -$83.69M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$22.88M 10-Q · filed 2023-05-15 | -$49.57M derived: sum of 2 quarters · filed 2024-02-29 | -$64.18M derived: sum of 3 quarters · filed 2024-02-29 | -$84.21M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$26.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$41.30M derived: sum of 2 quarters · filed 2024-02-29 | -$61.34M derived: sum of 3 quarters · filed 2024-02-29 | -$79.68M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$14.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$34.64M derived: sum of 2 quarters · filed 2022-11-04 | -$52.99M 10-Q · filed 2022-11-04 | -$76.38M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$20.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$38.38M 10-Q · filed 2022-08-05 | -$61.77M derived: sum of 3 quarters · filed 2022-08-05 | -$75.28M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$18.35M 10-Q · filed 2022-05-06 | -$41.74M derived: sum of 2 quarters · filed 2022-05-06 | -$55.25M derived: sum of 3 quarters · filed 2022-05-06 | -$77.83M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$23.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$36.90M derived: sum of 2 quarters · filed 2022-02-25 | -$59.49M derived: sum of 3 quarters · filed 2022-02-25 | -$70.80M 10-K · filed 2022-02-25 |
| 2020-09-30 | -$13.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$36.09M derived: sum of 2 quarters · filed 2021-11-12 | -$47.41M 10-Q · filed 2021-11-12 | -$59.06M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$22.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$33.90M 10-Q · filed 2021-08-13 | -$45.55M derived: sum of 3 quarters · filed 2022-02-25 | -$58.76M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$11.32M 10-Q · filed 2021-05-13 | -$22.97M derived: sum of 2 quarters · filed 2022-02-25 | -$36.18M derived: sum of 3 quarters · filed 2022-02-25 | -$41.50M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$24.86M derived: sum of 2 quarters · filed 2022-02-25 | -$30.18M derived: sum of 3 quarters · filed 2022-02-25 | -$35.63M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$13.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$18.53M derived: sum of 2 quarters · filed 2020-11-12 | -$23.98M 10-Q · filed 2020-11-12 | -$26.05M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$5.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$10.77M 10-Q · filed 2020-08-12 | -$12.84M derived: sum of 3 quarters · filed 2020-08-12 | -$14.80M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$5.44M 10-Q · filed 2020-05-13 | -$7.52M derived: sum of 2 quarters · filed 2020-05-13 | -$9.48M derived: sum of 3 quarters · filed 2020-05-13 | |
| 2018-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$4.04M derived: sum of 2 quarters · filed 2020-03-16 | -$4.63M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.55M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$589.00K 10-Q · filed 2019-08-12 |